What Is EVO?
EVO ICL is an implantable lens that corrects nearsightedness with and without astigmatism through a minimally invasive procedure.
EVO ICL is an implantable lens that corrects nearsightedness with and without astigmatism through a minimally invasive procedure.
EVO ICL is a special type of lens that is implanted between your iris (the colored part of the eye) and your natural crystalline lens. It’s biocompatible and works with your natural eye: think additive, not replacement nor subtractive.
Quick Facts
- FDA Approved
- ICL = Implantable Collamer® Lens
- Doesn’t remove any part of your natural eye
- For people 21–45 years of age, who have myopia with and without astigmatism
Quick Procedure, Quick Recovery, Great Eyesight



So, is this like LASIK?
Sort of- but not really! EVO ICL is a premium option for patients who might also be considering other laser-based procedures, such as LASIK and PRK.
EVO
LASIK
PRK
Safety Features
Reversible lens implant
Flexibility for future procedures
Treats eyes with thin corneas⁹
UV Protection
Long term history
Vision Quality
Sharp and Clear Vision²'³
Patient Experience
20-30 Minute Outpatient Procedure
No Corneal Tissue Removed
Does Not Cause Dry Eye Syndrome⁵'⁶
Lasik and PRK may cause Dry Eye Syndrome⁷'⁸
UV: ultraviolet.
* There is a limit flexibility if future procedures involve the cornea.
** Not applicable
*** Limited
Ready to get started?
Find a DoctorAll About the EVO ICL Implantable Collamer® Lens
EVO ICL is made from Collamer® – which contains collagen and poly-HEMA, making it biocompatible.
EVO ICL is additive and it works with the natural eye. So, unlike other vision correction procedures, corneal tissue will not be removed from your eye.
The lens is soft and pliable, making it gentle to implant in your eye. You won’t notice it’s there and a doctor can remove it at any point.
Fun Fact: Collamer® is proprietary to STAAR Surgical!
Here’s what to expect:
Overall, the procedure from evaluation to recovery is typically quick!

Take our quiz to make sure you are initially qualified for EVO ICL. We’ll ask you for your age and make sure you are nearsighted.

Check out our doctor finder to locate providers near you.

Your doctor will perform a series of standard tests to measure your eye’s unique characteristics, determine if EVO ICL is right for you, and order EVO lenses personalized for your prescription.

The procedure is quick, and painless because of the numbing medication! Your doctor will administer eye drops to dilate your pupils as well as anesthetize your eyes. Then your doctor will create one small opening at the base of your cornea to insert the EVO ICL lens. Once inserted, the doctor will make any necessary adjustments to ensure proper positioning in the eye.

Many patients notice improved vision nearly immediately. Your doctor will prescribe eye drops to aid in the healing process following the procedure. You’ll need someone to drive you home that day, but your doctor will let you know when you’re cleared to resume your day-to-day activities.
Our goal is for you to see life clearly, safely
3 Million +ICL Lenses distributed worldwide
99.4%Patients surveyed would do it again¹
Ready to Get Started?
Are You a Good Candidate for EVO ICL?
Take our quizFind a Doctor
Start your searchSelect Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263.
6. Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
7. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
8. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
9. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Feeling unsure?
We get it. Decisions like this take time to consider and research. We can help guide your decision with information that's the most relevant to you.
Do you currently wear glasses or contacts?